undamentalytics Newsletter
Sign in

Siga Technologies Inc revenue

Siga Technologies Inc's revenue was $94.6m in fiscal 2025, down 31.8% on the year before. Since fiscal 2016 ($15.0m) it has grown at a compound 22.7% a year. Over the last twelve months it was $53.7m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1512477271251341111401399554
Growth on the year before—−18.1%+>999%−94.4%+367.3%+7.0%−17.1%+26.3%−0.9%−31.8%—
Gross profit1512382251101171001221076529
Gross margin100.0%100.0%80.0%93.3%88.2%87.6%90.6%87.3%77.4%68.6%54.4%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Product Sales and Supportive Services $88M 93.1% ▼ 34.0%
Research and Development $6.5M 6.9% ▲ 21.1%
Geography
Region Revenue YoY
United States $88.8M ▼ 23.3%
Canada $5.8M ▲ 689.1%
Outside the US $5.8M ▼ 74.7%
Asia Pacific $0 ▼ 100.0%
EMEA $0 ▼ 100.0%

These categories overlap or exclude eliminations, so shares aren't shown.

From Siga Technologies Inc's 10-K filed March 10, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Siga Technologies Inc $53.7m -70.1% -18.1%
Tango Therapeutics, Inc. $53.8m 121.5% 16.9%
Gossamer Bio, Inc. $53.3m 32.4% —
Nektar Therapeutics $54.6m -27.2% -14.6%
Ocular Therapeutix, Inc $52.1m -8.1% -1.6%
Invivyd, Inc. $58.4m 26.3% —

Compare with peers

Head to head: SIGA vs TNGXGOSS vs SIGANKTR vs SIGAOCUL vs SIGA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Siga Technologies Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Siga Technologies Inc.